Shanghai, China

Jinlong Yang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fbc (Shanghai) Pharmaceutical Technology Co., Ltd., Kewpie Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinlong Yang. Retrieved from https://idiyas.com/inventor/jinlong-yang-9i6srh8z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jinlong Yang - Innovator in Pharmaceutical Technology

Introduction

Jinlong Yang is an inventor based in Shanghai, China. He has made contributions to the field of pharmaceutical technology, particularly through his work with various companies. Although he currently holds no granted patents, his innovative ideas are reflected in his patent applications.

Latest Patent Applications

One of Jinlong Yang's notable patent applications is titled "Cationic Hyaluronic Acid Coated Spanlastics and Preparation and Application Thereof." This application describes a cationic hyaluronic acid coated spanlastic, which comprises a drug-loaded vesicle. The surface of the drug-loaded vesicle is modified by cationic hyaluronic acid. The drug-loaded vesicle consists of a vesicle membrane and a hydrophobic drug wrapped by the vesicle membrane. The vesicle membrane is composed of a nonionic surfactant and an edge activator.

Conclusion

Jinlong Yang is an emerging inventor in the pharmaceutical technology sector, with a focus on innovative drug delivery systems. His work, although not yet recognized through granted patents, showcases his potential in advancing medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…